Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the submission of a Biologics License Application (BLA) to the U.S.
Cowen’s Eric Schmidt sees an extra several hundred million dollars in sales for EXEL in HCC market.
Exelixis, Inc. (NASDAQ:EXEL) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 30% upturn.
Celsion Corporation (NASDAQ:CLSN) announced publication of the manuscript, “Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable …
This market-beating fund manager is slashing ACRX and SGYP, but upping ATRS.
Fears about financial control should be a buying opportunity in Valeant stock, says Cantor.
Investors are racing to buy PhaseRx Inc (NASDAQ:PZRX) shares, after the biopharmaceutical company said its board of directors has begun a review of strategic …
The complete response letter: Antares and AcelRx have just gotten the kind of mail no one wants to receive.
Tim Chiang now sees a bigger per share value for ARDX’s tenapanor in the IBS-C market.
Ardelyx’s drug tenapanor gets closer to FDA approval; Cantor’s Mara Goldstein weighs in.
